期刊文献+

肝性脑病患者中神经介质内皮素,血栓素B_2和6-酮-前列腺素F1α的变化

Changes of neurotransmitter endothelin,thromboxance B_2 and 6-keto-prostaglandin F1 alpha in patients with hepatic encephalopathy and clinical significance
下载PDF
导出
摘要 目的研究肝性脑病(HE)患者内皮素(ET),血栓素B2(TXB2)和6-酮-前列腺素F1α(6-K-PGF1α)变化及其临床意义。方法HE患者62例,其中肝炎后肝硬化43例,乙型慢性重型肝炎19例。采用放免法测定血浆ET,TXB2和6-K-PGF1α。另选献血者30例作为正常对照。结果所有患者均肝肾功能异常。与正常对照比较,无论肝硬化还是慢性重型肝炎引起的HE,血浆ET和TXB2均明显升高(P<0.01),而6-K-PGF1α则明显下降(P<0.01),但肝硬化和慢性重肝炎之间血浆ET,TXB2和6-K-PGF1α变化无差异(P>0.05)。血浆ET和TXB2升高与6-K-PGF1α降低呈负相关(r=-0.4562,P<0.05)。结论HE患者血浆ET,TXB2和6-K-PGF1α可发生明显改变,这一变化对研究HE有一定的临床意义。 Objective To explore the changes of the neurotransmitters in patients with hepatic encephalopathy (HE)and the clinical significance. Methods Sixty-two patients with HE (37 males, 25 females, mean age 61.6 years old )were enrolled in the study, including 43 patients with post-hepatitic cirrhosis and 19 with chronic severe hepatitis B. Plasma endothelin (ET), thromboxance B2 (TXB2 )and 6-keto-prostaglandin F1 alpha( 6-K-PGF1 α)were detected by radioimmunoassay. Thirty blood donors were selected as normal controls. Results Compared with the normal controls,the levels of plasma ET and TXB2 were significantly elevated ( P 〈 0.01 ) and 6-K-PGF1α lowered( P 〈0.01 )in the HE patients ,but there was no significant difference between the patients with post-hepatitic cirrhosis and chronic severe hepatitis B ( P 〉 0.05 ). Elevated plasma ET and TXB2 were negatively related to the reduced 6-K-PGF1 α (r = -0.456 2, P 〈 0.05 ). Conclusion The results indicate that apparent changes of plasma ET and ,TXB2 and 6-K-PGF1α in the HE could provide a clinical significance for studying the HE.
出处 《山西医科大学学报》 CAS 2009年第11期1017-1019,共3页 Journal of Shanxi Medical University
基金 陕西省卫生厅科研基金资助项目(2004D26)
关键词 肝性脑病 神经介质 慢性重型肝炎 肝硬化 内皮素 血栓素B2 6-酮-前列腺素F1Α hepatic encephalopathy neurotransmitter chronic severe hepatitis liver cirrhosis endothelin thromboxanceB2 6-keto-prostaglandin F1 alpha
  • 相关文献

参考文献12

  • 1Haussinger D, Schliess F. Pathogenetic mechanisms of hepatic encephalopathy [J]. Gut,2008,57 ( 8 ) : 1156 - 1165.
  • 2Cordoba J, Minguez B. Hepatic eneephalopathy [ J ]. Semin Liver Dis ,2008,28 ( 1 ) :70 - 80.
  • 3Zwingmann C. Nuclear magnetic resonance studies of energy metabolism and glutamine shunt in hepatic encephalopathy and hyperammonemia[J]. J Neurosci Res,2007,85 ( 15 ) :3429 - 3442.
  • 4Garcta-Ayllon MS, Cauli O, Silveyra MX, et al. Brain cholinergic impairment in liver failure [J]. Brain,2008,131 ( Pt 11 ) :2946 - 2956.
  • 5Subhash HS, Heddle RJ, Schuhz DW, et al. Hepatic encephalopathy precipitated by sodium valproate therapy [ J ]. Med J Aust, 2008,188 (9) :549.
  • 6Cauli O, Rodrigo R, Boix J, et al. Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain[J]. Am J Physiol Gastrointest Liver Physiol, 2008,295 (3) :G503 -511.
  • 7Lemberg A, Fernandez MA. Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress [ J ]. Ann Hepatol,2009, 8(2) :95 -102.
  • 8Kamel L, Saleh A, Morsy A, et al. Plasma met-enkephalin, beta- endorphin and leu-enkephalin levels in human hepatic encephalopathy[ J]. East Mediterr Health J ,2007,13 (2) :257 -265.
  • 9Roser M, Josic D, Kontou M,et al. Metabolism of galactose in the brain and liver of rats and its conversion into glutamate and other amino acids [ J ]. J Neural Transm ,2009,116 ( 2 ) : 131 - 139.
  • 10Monfort P, Cauli O, Montoliu C, et al. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy:thera- peutical implications [ J ]. Nearochem Int, 2009, 55 ( 1 - 3 ) : 106 - 112.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部